Please provide your email address to receive an email when new articles are posted on . A clinical-stage biotechnology company announced that it has raised $150 million in funding to advance its ...

BOSTON & SAN DIEGO--(BUSINESS WIRE)--Rapport Therapeutics, Inc., a clinical-stage biotechnology company leveraging the science of receptor-associated proteins (RAPs) to advance precision ...

University of Florida Health in Gainesville will open the UF Health Heart & Vascular Hospital and the UF Health Neuromedicine Hospital next month. In a news release, UF Health said the $415 million ...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Ceretype Neuromedicine, a pioneer in the practical application and integration of functional MRI (fMRI), announced today that it has closed its second round of seed ...

Today we officially welcome patients into the new UF Health Heart & Vascular Hospital and the UF Health Neuromedicine Hospital. This historic milestone for the University of Florida and UF Health ...

Rapport Therapeutics Inc. raised $150 million in a series B round, less than six months after unveiling its $100 million series A investment. It’s further evidence that its distinctive precision ...

New research details how the complex set of molecular and fluid dynamics that comprise the glymphatic system - the brain's unique process of waste removal - are synchronized with the master internal ...

Rochester, N.Y. (WHAM) - A new first-of-its-kind facility is opening in the Rochester area for people on the autism spectrum. UR Medicine held a grand opening Wednesday for its Neuromedicine & ...

- Raymond Kelleher, M.D., Ph.D., of lead investor Cormorant Asset Management, and James Healy, M.D., Ph.D., of Sofinnova Investments, join Board of Directors BOSTON ...